about
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesThe blind men 'see' the elephant-the many faces of fatty liver diseaseAssociation between hepatitis B virus and pancreatic cancerImpact of new treatment options for hepatitis C virus infection in liver transplantationHepatitis C and liver transplantationSCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In VitroHepatitis C.Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European DatabankFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CHepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferonRole of living donor liver transplantation in the treatment of hepatitis C virus infectionInvestigation of Transforming Growth Factor-β1 Gene Polymorphisms Among Iranian Patients With Chronic Hepatitis C.Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.Prevalence of Hepatitis B, Hepatitis C and HIV and Related Risk Factors in Contact Sportsmen in Zanjan: A Letter to Editor.Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.Triterpenoid Saponins Isolated from Platycodon grandiflorum Inhibit Hepatitis C Virus ReplicationOptimizing the treatment of chronic viral hepatitis C.A Novel Structurally Stable Multiepitope Protein for Detection of HCV.Asymmetric synthesis of cyclopropyl-fused 2'-C-methylcarbanucleosides as potential anti-HCV agents.Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 PatientsDesign and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.Synthesis and anti-HCV evaluation of 4'(alpha)-ethyl and 2'(beta)-methyl-carbodine analogues.Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells.Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model.Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation.Hepatitis C virus core and NS3 antigens induced conjunctival inflammation via toll-like receptor-mediated signalingInterleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin.Patient education and treatment strategies implemented at a pharmacist-managed hepatitis C virus clinic.Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.
P2860
Q24276096-EAD5B8A4-C03C-4ECE-A26B-BD59734C23ADQ24654991-A182CA97-44F8-4E86-8B74-C0F7369F631CQ24656650-5338F2D9-5EAA-40A0-844E-F8CD26D27D15Q26782017-443D7D19-3FFD-415F-8783-7ABCE864F09AQ27490388-4F5A8C7B-153B-4E3A-81A6-891946F718D7Q27490844-20C18611-A300-43A3-937B-B720D942BFBBQ28084654-AAC68601-D43A-4FF1-8A46-2C70114E51DBQ28553430-6616FF75-7409-4E54-A084-31C31BFA1761Q30235178-517BCF90-EDAD-4AF4-85DD-8A5C751E40EEQ33835218-02DEB8BF-C85B-4948-8113-3EDE005070CCQ34023159-65B42926-9B44-453F-BB8D-0B05955BF9EDQ35540281-1EDA051E-4F83-4040-BE65-1E58FECE7902Q35764246-86885BDD-962E-40D8-83FA-817BCC2F0AE9Q36001720-07DEA7B0-51BE-4FA9-9C08-0A8F0189BBE3Q36279445-40FAAD18-7C81-4846-8FFD-824999131D71Q37111098-4915FA2E-28BD-4846-BF05-491D4C760A46Q37486646-28106E6A-E46D-4F50-A51A-D67A8C83D0C6Q37636095-947432FF-331A-4B78-B5B2-1A6EFF4AFD65Q38363018-C7A77BAA-3E8D-4CB5-9C96-7755C640F656Q38503248-DFC95F40-011E-45F1-884C-02FB66D5ED85Q39398874-34A576AE-AB38-4CE9-B011-43D69B761937Q39502501-147833CF-3560-4C31-B4C1-CCD020B22F22Q39735236-63BAF756-41F0-4067-8391-6BF4CDFC30F5Q39788612-CEB9F60C-5003-420F-B68D-2807311C3AFCQ40593359-1F5107A1-DE6F-4A65-9C40-845C452955F3Q41673507-58B819D2-CC50-458F-8DA2-8DFBCBDDCADFQ41685645-0ADC66C4-FABF-4079-94FD-2F207E3937B2Q42978534-CB682DD3-826F-4B27-B6FB-71A139AA0F06Q42990347-8606C6ED-1E4D-4521-AEE4-CDB6ABEC371AQ45423867-15DB8DAB-F7B9-497E-B895-4EA0AB7A41B3Q47139887-8E985124-334D-4B04-AFC4-661E0798A0EB
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Viral hepatitis: new data on hepatitis C infection.
@ast
Viral hepatitis: new data on hepatitis C infection.
@en
type
label
Viral hepatitis: new data on hepatitis C infection.
@ast
Viral hepatitis: new data on hepatitis C infection.
@en
prefLabel
Viral hepatitis: new data on hepatitis C infection.
@ast
Viral hepatitis: new data on hepatitis C infection.
@en
P2093
P2860
P356
P1476
Viral hepatitis: new data on hepatitis C infection.
@en
P2093
András Kiss
Csilla Páska
Erzsébet Szabó
Gábor Lotz
Zsuzsa Schaff
P2860
P2888
P304
P356
10.1007/BF02893380
P577
2003-12-22T00:00:00Z